| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 544072000 | Plural oxazine rings | 47 |
| 544073000 | Polycyclo ring system having oxazine ring as at least one of the cyclos | 20 |
| 20090270615 | METHOD OF PREPARING BENZOXAZINES - This invention relates to a novel synthesis for the preparation of benzoxazine components from phenolic components, aldehyde components, and amine components in a solvent other than toluene. | 10-29-2009 |
| 20090299062 | THERMOSETTING COMPOUND, COMPOSITION CONTAINING THE SAME, AND MOLDED ARTICLE - The object of the present invention is to provide a thermosetting compound having dielectric properties, in particular permittivity and dielectric loss, which are improved compared to prior art, a composition containing the same, and a molded article. The thermosetting compound according to the present invention is a dihydro benzoxazine compound represented by the following Formula (2), | 12-03-2009 |
| 20110003985 | CYCLOPENTAPHENANTHRENE-BASED COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME - Provided are a cyclopentaphenanthrene-based compound and an organic EL device using the same. The cyclopentaphenanthrene-based compound is easy to prepare and excellent in solubility, color purity, and color stability. The cyclopentaphenanthrene-based compound is useful as a material for forming an organic layer, in particular, a light-emitting layer in an organic EL device, and as an organic dye or an electronic material such as a nonlinear optical material. | 01-06-2011 |
| 20120116078 | PHOSPHORUS-CONTAINING BISPHENOLS AND PREPARING METHOD THEREOF - The Phosphorus-containing bisphenols and preparing method thereof are disclosed. A method for producing the phosphorus-containing bisphenol of the formula (1) includes reacting compounds respectively defined by a formula (a), (b), (c) and an acid catalyst to yield compounds of phosphorus-containing bisphenol. | 05-10-2012 |
| 20120178924 | HEXAHYDROOXAZINOPTERINE COMPOUNDS - The present invention relates to intermediates of the formula | 07-12-2012 |
| 20130190491 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION - Compounds of formula I: | 07-25-2013 |
| 20140163224 | USE OF TETRAHYDROBENZOXAZINES AS STABILISERS - The use of tetrahydrobenzoxazines I | 06-12-2014 |
| 20140206864 | BENZOXAZINE INTERMEDIATE AND PREPARATION METHOD THEREOF - The present invention relates to a benzoxazine intermediate and a preparation method thereof. The structural formula of the benzoxazine intermediate is shown by formula (1), R | 07-24-2014 |
| 20160141516 | LIGHT EMITTING MATERIAL, DELAYED FLUORESCENT EMITTER, ORGANIC LIGHT EMITTING DEVICE, AND COMPOUND - A compound represented by the following general formula is useful as a light emitting material. X represents an oxygen atom or a sulfur atom. R | 05-19-2016 |
| 544074000 | Plural 1,4-oxazine rings are cyclos in the polycyclo ring system | 11 |
| 20080200673 | Process for The Preparation of Sulfonic Acid Salts of Oxabispidines - There is provided a process for the isolation of a sulfonic acid salt of formula I, or a solvate thereof, from a mixture comprising: (i) the corresponding free base; and (ii) a compound of formula III. or a salt and/or solvate thereof, which process comprises providing an aqueous dispersion of the compounds of formulae II and III and a source of R | 08-21-2008 |
| 20080207899 | Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias - There is provided compounds of formula I, wherein R | 08-28-2008 |
| 20080207900 | TWO CYCLIC OXOMORPHORIN DERIVATIVES - The present invention relates to a compound represented by formula (I): | 08-28-2008 |
| 20090005558 | Novel Oxabispidine Compounds and Their Use in the Treatment of Cardiac Arrhythmias - There is provided compounds of formula (I), wherein R | 01-01-2009 |
| 20090062532 | Chemical Intermediate - An acid addition salt of a compound of Formula I, wherein R | 03-05-2009 |
| 20090240051 | New process for the production of oxabispidines - There is provided a process for the preparation of a compound of formula I, | 09-24-2009 |
| 20090326221 | New oxabispidine compunds useful in the treatment of cardiac arrhythmias - There is provided compounds of formula I, | 12-31-2009 |
| 20100113773 | BICYCLIC OXOMORPHOLINE DERIVATIVE - The present invention relates to a compound represented by formula (I): | 05-06-2010 |
| 20110098466 | Synthesis Of Triphenodioxazine Pigments - The invention relates to a process for the preparation of compounds of the general formula (I) where X are halogen atoms, the rings labeled A are linearly or angularly fused in position 1,2; 2,3 or 3,4, and in position 8,9; 9,10 or 10,11, to a 5- or 6-membered heterocyclic ring containing in the ring one nitrogen atom and one oxygen atom, or containing in the ring two nitrogen atoms, comprising an oxidation of a 3,6-bisarylamino-2,5-dihalobenzoquinone of the formula (II) in an aprotic-polar organic solvent in the presence of an organic sulfonic acid. | 04-28-2011 |
| 20160137844 | CARBAZOLE DIOXAZINE PIGMENT AND A METHOD FOR ITS PREPARATION - The present disclosure provides carbazole-dioxazine pigment of Formula I; | 05-19-2016 |
| 544075000 | Pentacyclo ring system having the oxazine rings as cyclos | 1 |
| 20080234480 | Triphendioxazine Pigments - The invention relates to novel triphendioxazine pigments of formula (I) | 09-25-2008 |
| 544078000 | Plural morpholine rings (i.e., plural fully hydrogenated 1, 4-oxazine rings) | 27 |
| 544079000 | Polycyclo ring system | 13 |
| 20090062533 | NAPHTHOLS USEFUL FOR PREPARING INDENO-FUSED PHOTOCHROMIC NAPHTHOPYRANS - Described are naphthols useful in the manufacture of novel indeno-fused photochromic naphthopyran materials. | 03-05-2009 |
| 20110269955 | METHOD FOR PREPARING 2-MORPHOLINOISOBORNANE- 10-THIOL AND INTERMEDIATES FORMED THEREIN - A method for preparing 2-morpholinoisobornane-10-thiol is disclosed, which has simplified steps and avoids the use of Na metal. Accordingly, it is advantageous to apply the method in a mass production. | 11-03-2011 |
| 20120136148 | Photochromic Compounds Having At Least Two Photochromic Moieties - The present invention relates to photochromic compounds that include at least two photochromic moieties that are linked together by a multivalent linking group. The multivalent linking group can be selected so as to be flexible and/or substantially prevent electronic interaction between any two photochromic moieties through the multivalent linking group. The present invention also relates to photochromic compositions and articles that include at least a photochromic amount of one or more photochromic compounds of the present invention. | 05-31-2012 |
| 20120214992 | PHOTOCHROMIC MATERIALS THAT INCLUDE 6-AMINO SUBSTITUTED INDENO-FUSED NAPHTHOPYRANS - The present invention relates to photochromic materials that include certain indeno-fused naphthopyrans. The indeno-fused naphthopyrans have an amino group (e.g., a piperidino or morpholino group) bonded to the 6-position and hydrogen or a halo group (e.g., fluoro) bonded to the 11-position thereof. The photochromic materials of the present invention can have a closed-form electromagnetic radiation absorption spectrum that is shifted to longer wavelengths (e.g., wavelengths of greater than 390 nm), relative to comparable photochromic materials. The present invention also relates to optical elements, such as eyeglasses, that include the photochromic materials of the present invention. | 08-23-2012 |
| 20140256936 | DIARYLETHENE COMPOUNDS AND USES THEREOF - A compound according to Formula IA and IB, reversibly convertible under photochromic and electrochromic conditions between a ring-open isomer A and a ring-closed isomer B is provided. For substitutent groups, Z is N, O or S; each R | 09-11-2014 |
| 20160083398 | DIARYLETHENE COMPOUNDS AND USES THEREOF - A compound according to Formula IA and IB, reversibly convertible under photochromic and electrochromic conditions between a ring-open isomer A and a ring-closed isomer B is provided. For substitutent groups, Z is N, O or S; each R | 03-24-2016 |
| 544080000 | Ring nitrogen in the polycyclo ring system | 7 |
| 20090156803 | Condensed furan compounds - The present invention provides a condensed furan compound of the formula (I): | 06-18-2009 |
| 20120130069 | NOVEL INDAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS PROTEIN KINASE INHIBITORS FOR PROLIFERATIVE DISEASES TREATMENT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT - Disclosed are novel indazole derivatives represented by the following Chemical Formula 1 or pharmaceutically acceptable salts, hydrates or solvates thereof, and pharmaceutical compositions for the prevention or treatment of proliferative diseases, containing the same as an active ingredient. Having potent inhibitory effect against protein kinase, such as b-raf, KDR, Fms, Tie2, SAPK2a and Ret, inducing diseases caused by abnormal cell proliferation, the novel indazole derivatives can be used for the prevention or treatment of diseases caused by abnormal cell proliferation. | 05-24-2012 |
| 20120277424 | 2,7-SUBSTITUTED THIENO[3,2-D] PYRIMIDINE COMPOUNDS AS PROTEIN KINASE INHIBITORS - Disclosed are a 2,7-substituted thieno[3,2-d]pyrimidine compound having a protein kinase inhibition activity, a pharmaceutically acceptable salt, and a pharmaceutical composition for prevention and treatment of diseases caused by abnormal cell growth comprising the compound as an effective ingredient. | 11-01-2012 |
| 20140005383 | 1H-PYRAZOLO[3,4-B]PYRIDINES AND THERAPEUTIC USES THEREOF | 01-02-2014 |
| 544081000 | Four or more ring nitrogens in the polycyclo ring system | 3 |
| 20110172418 | ANTISENSE RESTENOSIS COMPOSITION AND METHOD - The present invention provides an improved method for reducing the risk or severity of restenosis following cardiac angioplasty. The method includes administering to a target vessel region, a morpholino antisense compound having a phosphorus-containing backbone linkages, and spanning the start codon of a human c-myc mRNA. Also disclosed are novel antisense compounds and compositions, and a method for assaying the effectiveness of antisense delivery and uptake to a target vessel region. | 07-14-2011 |
| 20130053556 | Photocleavable morpholino oligos with integral photolinkers for modulating the activity of any selected gene transcript by exposure to light - Morpholinos are widely used to block the activity of selected single-stranded genetic sequences. This invention comprises Morpholinos containing one or more integral photolinkers (Photo-Morpholinos) wherein the photolinkers are directly incorporated into the sequence of a Morpholino, where the photolinker has a size and structure which emulates the size and structure of a Morpholino subunit. This integrated photolinker design substantially simplifies and reduces cost of production relative to earlier photocleavable compositions. | 02-28-2013 |
| 20140221646 | NOVEL IMMUNE SYSTEM MODULATORS - The present invention relates to a compound of Formula I: | 08-07-2014 |
| 544082000 | Additional nitrogen containing hetero ring (e.g., thiazole, etc.) | 11 |
| 20110065919 | 5-Substituted Indol-3-Carboxylic Acid Derivatives Exhibiting Antiviral Activity a Method for the Production and Use Thereof - The invention relates to novel antiviral compounds of general formula (I), where B is —N(R)2 or —O—(CH2)nN(R)2 groups, in which n is a whole number selected from 0, 1, 2, 3 and 4, each R is independently selected from C1-4 alkyl and can be identical or different, or both groups R together with a nitrogen atom, to which they are bonded, form a 5-6-membered heterocyclic ring containing 1-2 heteroatoms selected from nitrogen, oxygen and sulphur, such as pyrrolidine, piperidine, piperazine, morpholine or thyomorpholine, at which each of above-mentioned heterocyclic rings can be substituted by C1-4 alkyl, phenyl, benzyl, phenetyl, a carbonylamino —COOC1-4 alkyl group or the carbonylamino —COOC1-4 alkyl group and phenyl, which also can be substituted and have substituents selected from halogen, C1-4 alkyl, C1-4 alkoxy, and alkyl in said groups can be linear or branched; R1 is C1-4 alkoxy, phenyl optionally substituted by C1-4 alkyl or C1-4 alkoxy, halogen atoms, naphthyl; R2 is C1-4 alkyl, —S-phenyl, —S-benzyl, —O-phenyl, O-benzyl, wherein in each of the above-mentioned groups the phenyl ring is optionally substituted by C1-4 alkyl, C1-4 alkoxy, halogen atoms, or R2 is an —NR3R4 group, in which R3 and R4, each is independently selected from C1-4 alkyl and can be identical or different, or both R3 and R4 groups together with a nitrogen atom, to which they are bonded, form a 5-6-membered nitrogen-containing heterocyclic ring having the above mentioned value for the N(R)2 group; X is hydrogen or a halogen atom selected from Br, Cl, and I or pharmaceutically acceptable salts thereof. Intermediate products of general formula (II) and a method for producing the inventive compounds are also disclosed | 03-17-2011 |
| 20110152519 | PYRIMIDINE DERIVATIVE HAVING CELL PROTECTING EFFECT AND USES THEREOF - [Problem] To provide a prophylactic/therapeutic agent against, for example, nerve diseases and the like such as ischemic brain disease and neurodegenerative disease, or a prophylactic/therapeutic agent against diseases against which antioxidant action is effective, as a cell protecting agent, in particular as an inhibitor of brain cell damage or brain cell death. | 06-23-2011 |
| 20110269956 | Hepatitis C Virus Inhibitors - The present disclosure relates to methods for making compounds useful in the treatment of Hepatitis C virus (HCV) infection. | 11-03-2011 |
| 20120035358 | Molecular transporter compositions comprising dendrimeric oligoguanidine with a tri-functional core that facilitates delivery into cells in vivo - Novel molecular transporter compositions and their use for transporting bioactive substances into cells in living animals are disclosed. To afford in vivo delivery, the composition is covalently linked to the bioactive substance and the resultant composite structure is introduced into the subject. The transporter composition includes multiple guanidine moieties on a dendrimeric scaffold having a tri-functional core. The tri-functional core is a phosphorodiamidate or phosphoramide moiety. | 02-09-2012 |
| 20130005963 | ORGANIC PHOTOELECTRIC CONVERSION MATERIAL AND ORGANIC THIN-FILM PHOTOELECTRIC CONVERSION DEVICE - An organic photoelectric conversion material for use in an organic thin-film photoelectric conversion device, containing a compound represented by formula 1; and an organic thin-film photoelectric conversion device having a photoelectric conversion layer which containing the organic photoelectric conversion material: | 01-03-2013 |
| 20130253187 | Process for Determining the Suitability for Distribution of a Batch of Thiophene-2-Carboxamide Derivative - The present invention relates to a process for determining the suitability for distribution of a batch of rivaroxaban or of a pharmaceutical composition thereof. In particular, it also relates to two impurities of rivaroxaban, to their use as reference markers to determine the purity of a sample of rivaroxaban or a composition thereof, to analytical methods for determining the purity of a sample of rivaroxaban or a composition thereof and to a process of preparing rivaroxaban or pharmaceutical compositions thereof which are free or substantially free of such impurities. | 09-26-2013 |
| 20130317213 | Hepatitis C Virus Inhibitors - The present disclosure relates to methods for making compounds useful in the treatment of Hepatitis C virus (HCV) infection. | 11-28-2013 |
| 20150011754 | Hepatitis C Virus Inhibitors - The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection. | 01-08-2015 |
| 20160031816 | ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS - The present invention provides compounds of Formula (I): | 02-04-2016 |
| 20160076033 | MORPHOLINO OLIGONUCLEOTIDE MANUFACTURING METHOD - Using a morpholino nucleotide wherein 5′-hydroxy group or a hydroxy group present on the substituent of the 5′-hydroxy group is protected by a protecting group having an alkyl group having not less than 10 and not more than 300 carbon atoms and/or an alkenyl group having not less than 10 and not more than 300 carbon atoms as a starting material, a method capable of efficiently producing the morpholino oligonucleotide in a high yield by a liquid phase synthesis can be provided. | 03-17-2016 |
| 20160251334 | MANUFACTURING PROCESS FOR PYRIMIDINE DERIVATIVES | 09-01-2016 |
| 544084000 | Phosphorus attached directly or indirectly to a morpholine ring by nonionic bonding | 1 |
| 20160186174 | SUBSTITUTED MORPHOLINO COMPOUNDS ANALOGS THEREOF AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM - The present invention provides substituted morpholino compounds, analogs thereof and oligomeric compounds prepared therefrom. More particularly, incorporation of one or more of the substituted morpholino compounds into an oligomeric compound is expected to enhance one or more properties of the oligomeric compound. Such oligomeric compounds can also be included in a double stranded composition. In certain embodiments, the oligomeric compounds provided herein are expected to hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA. | 06-30-2016 |
| 544086000 | Nitrogen attached directly or indirectly to a morpholine ring by nonionic bonding | 1 |
| 20100022769 | NOVEL POLYNITROGENATED SYSTEMS AS ANTI-HIV AGENTS - The present invention describes the synthesis of the compounds of formulae (1), (2) and (3) in which m and n, which may be identical or different, may have the values 0, 2, 3, 4, 5 and 6; Z and Y, which may be identical or different, represent a nitrogenated cyclic system bonded by nitrogen or by one of the ring carbons or an NR | 01-28-2010 |
| 544087000 | Oxygen attached directly or indirectly to a morpholine ring by nonionic bonding | 1 |
| 20130066070 | PROCESS FOR PRODUCING ESTER COMPOUND - To provide an environmentally-friendly method for producing industrially an ester compound. | 03-14-2013 |
